Dambkowski Carl (CIK 1983476) reported 59 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-07-02). Recent activity: Buy APGE (4,125 shares), Sell APGE (5,500 shares), Sell APGE (26,400 shares), Sell ORKA (22,417 shares), Sell ORKA (12,583 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Apogee Therapeutics, Inc. (APGE) | Chief Medical Officer | Buy | 4,125 | $94,298 |
| 2026-07-02 | Apogee Therapeutics, Inc. (APGE) | Chief Medical Officer | Sell | 5,500 | $730,070 |
| 2026-06-24 | Apogee Therapeutics, Inc. (APGE) | Chief Medical Officer | Sell | 26,400 | $3.5M |
| 2026-06-12 | Oruka Therapeutics, Inc. (ORKA) | Director | Sell | 22,417 | $1.6M |
| 2026-06-12 | Oruka Therapeutics, Inc. (ORKA) | Director | Sell | 12,583 | $882,182 |
| 2026-06-05 | Apogee Therapeutics, Inc. (APGE) | Chief Medical Officer | Buy | 4,125 | $94,298 |
| 2026-06-05 | Apogee Therapeutics, Inc. (APGE) | Chief Medical Officer | Sell | 5,500 | $432,905 |
| 2026-05-22 | Oruka Therapeutics, Inc. (ORKA) | Director | Sell | 13,235 | $793,662 |
| 2026-05-22 | Oruka Therapeutics, Inc. (ORKA) | Director | Buy | 11,904 | $92,851 |
| 2026-05-22 | Oruka Therapeutics, Inc. (ORKA) | Director | Buy | 11,667 | $137,321 |
| 2026-05-22 | Oruka Therapeutics, Inc. (ORKA) | Director | Sell | 38,318 | $2.2M |
| 2026-05-22 | Oruka Therapeutics, Inc. (ORKA) | Director | Sell | 53,447 | $3.2M |
| 2026-05-22 | Oruka Therapeutics, Inc. (ORKA) | Director | Buy | 38,689 | $264,633 |
| 2026-05-08 | Apogee Therapeutics, Inc. (APGE) | Chief Medical Officer | Buy | 4,125 | $94,298 |
| 2026-05-08 | Apogee Therapeutics, Inc. (APGE) | Chief Medical Officer | Sell | 3,700 | $310,504 |
| 2026-05-08 | Apogee Therapeutics, Inc. (APGE) | Chief Medical Officer | Sell | 1,800 | $152,280 |
| 2026-04-03 | Apogee Therapeutics, Inc. (APGE) | Chief Medical Officer | Buy | 4,125 | $94,298 |
| 2026-04-03 | Apogee Therapeutics, Inc. (APGE) | Chief Medical Officer | Sell | 2,698 | $227,468 |
| 2026-04-03 | Apogee Therapeutics, Inc. (APGE) | Chief Medical Officer | Sell | 2,702 | $230,562 |
| 2026-04-03 | Apogee Therapeutics, Inc. (APGE) | Chief Medical Officer | Sell | 100 | $8,589 |
| 2026-03-06 | Apogee Therapeutics, Inc. (APGE) | Chief Medical Officer | Buy | 4,125 | $94,298 |
| 2026-03-06 | Apogee Therapeutics, Inc. (APGE) | Chief Medical Officer | Sell | 3,225 | $226,814 |
| 2026-03-06 | Apogee Therapeutics, Inc. (APGE) | Chief Medical Officer | Sell | 2,075 | $149,358 |
| 2026-03-06 | Apogee Therapeutics, Inc. (APGE) | Chief Medical Officer | Sell | 200 | $14,652 |
| 2026-02-04 | Apogee Therapeutics, Inc. (APGE) | Chief Medical Officer | Buy | 4,125 | $94,298 |
Source: SEC Form 4 filings · as of 2026-07-02